Hypoglycemic effects of date seed extract. Possible mechanism of action, and potential therapeutic implications

To investigate the possible mechanism, by which an extract from date seeds exert its hypoglycemic effect. This study was performed at the Anatomy Department, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia from May to December 2012. Eighty rats were divided into 4 groups. Group 1 received no treatment. Group 2 received daily ingestions of 10 ml of date seed extract for 8 weeks. Animals of groups 3 and 4 were made diabetic by streptozotocin injection, and were given daily subcutaneous injections of 3 IU/day of insulin for 8 weeks. Group 4 received, in addition, daily ingestions of 10 ml of seed extracts. Rats were sacrificed, and the sera were separated for estimation of serum C-peptide levels. Pancreatic tissues were processed for histological study of the islet cells, immunohistochemical study for insulin secretion and image analysis for insulin quantification. Mean serum C-peptide level was significantly higher in group 4 compared to group 3. Pancreatic islets from rats of group 3 showed weak immunoreactivity for insulin, while those of group 4 showed strong immunoreactivity in some hypertrophied beta cells. Immunopositive cells were detected in the wall of interlobular ducts and in centroacinar cells of pancreas only in group 4. Quantification of insulin immunoreactivity showed a marked reduction in islet size and extent of insulin immunoreactivity in diabetic compared to control groups. Date seed extracts may stimulate endogenous insulin secretion through extra-islet sources

extract from date seeds having a hypoglycemic effect

To investigate the safety of date seed extract administration, and to compare between toxic effects of diabetes on rats treated with insulin versus rats treated with insulin-seed extract. This study was performed in the Anatomy Department, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia from August to December 2010. One hundred rats were divided into 5 groups. Group 1 served as control. Group 2 was given daily ingestions of 10 ml of date seed extract. Animals of groups 3 and 4 were made diabetic by streptozotocin injection, and were given daily subcutaneous injections of 3 lU/day of insulin for 8 weeks. Group 4 received, in addition, daily ingestions of 10 ml of seed extract. Group 5 were made diabetic with streptozotocin and then given the seed extract only. At the end of experiment, rats were decapitated, and the sera were separated for estimation of alanine aminotransferase [ALT], aspartate aminotransferase, gamma glutamyl transferase, blood urea nitrogen, and serum creatinine levels. Livers and kidneys were processed for light microscopic study. The mean values of all tested serum levels were significantly higher in Group 3 compared to Groups 1, 2 and 4 [with the exception of ALT in the case of Group 4]. There was no significant change when comparing the mean values of Groups 1, 2, and 4. Livers and kidneys of rats in Groups 1, 2, and 4 showed normal histology, while those of Group 3 showed histopathological changes. Date seed extract administration is safe on the liver and kidney. In addition, insulin-date seed extract combination minimizes the toxic effects of diabetes on these organs